Genuv Inc.: Clinical Trials

1 trial sponsored by Genuv Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Genuv Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)
Trametinib (0.5 mg), Trametinib (1 mg), Riluzole (100 mg) - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2TerminatedGenuv Inc.232020-04-022023-05-09

Conditions studied

Amyotrophic Lateral Sclerosis (1)

Interventions

Riluzole (1)  ·  trametinib (1)

Countries

South Korea (1)

Top investigators

Byoung Joon Kim (1)